You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 18, 2025

Ohm Labs Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for OHM LABS

OHM LABS has eleven approved drugs.

There is one tentative approval on OHM LABS drugs.

Summary for Ohm Labs
US Patents:0
Tradenames:9
Ingredients:8
NDAs:11

Drugs and US Patents for Ohm Labs

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ohm Labs IBUPROFEN ibuprofen TABLET;ORAL 070818-001 Dec 26, 1985 DISCN No No ⤷  Try for Free ⤷  Try for Free
Ohm Labs Inc GUAIFENESIN guaifenesin TABLET, EXTENDED RELEASE;ORAL 209254-002 Jul 16, 2018 OTC No No ⤷  Try for Free ⤷  Try for Free
Ohm Labs IBUPROHM ibuprofen TABLET;ORAL 070469-001 Aug 29, 1985 DISCN No No ⤷  Try for Free ⤷  Try for Free
Ohm Labs LOPERAMIDE HYDROCHLORIDE loperamide hydrochloride TABLET;ORAL 074091-001 Dec 10, 1992 OTC No No ⤷  Try for Free ⤷  Try for Free
Ohm Labs CHLORZOXAZONE chlorzoxazone TABLET;ORAL 081298-001 Dec 29, 1993 DISCN No No ⤷  Try for Free ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Pharmaceutical Competitive Landscape Analysis: Ohm Labs – Market Position, Strengths & Strategic Insights

In the ever-evolving pharmaceutical industry, staying ahead of the competition is crucial for success. Ohm Laboratories, a subsidiary of Sun Pharmaceutical Industries, has carved out a significant position in the US market. Let's dive into a comprehensive analysis of Ohm Labs' market position, strengths, and strategic insights to understand its role in the competitive pharmaceutical landscape.

Company Overview

Ohm Laboratories, based in New Jersey, is a manufacturer of prescription and over-the-counter (OTC) drugs in solid dosage forms[2]. As a wholly-owned subsidiary of Ranbaxy Inc., which is now part of Sun Pharmaceutical Industries, Ohm Labs plays a crucial role in Sun Pharma's US operations[1][2].

Market Position

Ohm Labs has established itself as a key player in the US pharmaceutical market, particularly in the manufacturing of solid dosage forms. The company's integration into Sun Pharma's network has further strengthened its market position[2].

Product Portfolio

Ohm Labs specializes in:

  1. Prescription drugs
  2. Over-the-counter medications
  3. Controlled substances (with DEA approval)[2]

This diverse product range allows Ohm Labs to cater to various segments of the pharmaceutical market, enhancing its competitive edge.

Manufacturing Capabilities

Ohm Labs boasts state-of-the-art manufacturing facilities that set it apart in the industry. These facilities are equipped to handle:

  • High-volume products
  • Large batch sizes
  • Complex combinations and unique product deliveries[2]

The company's manufacturing prowess is a significant strength, enabling it to meet diverse market demands efficiently.

Supply Chain Efficiency

One of Ohm Labs' key strengths lies in its supply chain management. The company's efficient supply chain ensures seamless transportation of products to customer locations[2]. This capability is crucial in the pharmaceutical industry, where timely delivery can make a significant difference in patient care and market performance.

Research and Development

Ohm Labs demonstrates a strong commitment to research and development (R&D). In recent years, the company has invested significantly in R&D initiatives, including:

  • Outsourcing certain R&D projects
  • Entering into collaboration and license agreements for new product development
  • Focusing on formulations and injections of new products[1]

This emphasis on R&D positions Ohm Labs well for future growth and innovation in the competitive pharmaceutical landscape.

Financial Performance

While specific financial data for Ohm Labs is limited, we can glean some insights from available information:

  • In 2014, the company experienced a decline in quarterly sales, primarily due to supply chain issues related to FDA restrictions on a key facility[1]
  • Despite challenges, Ohm Labs continues to be a significant contributor to Sun Pharma's US operations

Regulatory Compliance

Ohm Labs has demonstrated its ability to navigate the complex regulatory landscape of the pharmaceutical industry. The company is:

  • Approved by the US Drug Enforcement Agency (DEA) to manufacture controlled substances[2]
  • Compliant with FDA regulations for pharmaceutical manufacturing

This regulatory compliance is a crucial strength in an industry where adherence to strict quality and safety standards is paramount.

Market Challenges

Like any pharmaceutical company, Ohm Labs faces several challenges in the competitive landscape:

  1. Regulatory scrutiny: The pharmaceutical industry is heavily regulated, and companies must constantly adapt to changing requirements.
  2. Price pressures: Increasing competition and healthcare cost containment efforts put pressure on drug prices.
  3. Supply chain disruptions: As evidenced by past experiences, supply chain issues can significantly impact sales and operations[1].

Strategic Insights

To maintain and improve its competitive position, Ohm Labs could consider the following strategies:

1. Focus on Niche Markets

By leveraging its manufacturing capabilities for complex combinations and unique product deliveries, Ohm Labs could focus on niche markets where competition is less intense.

2. Expand R&D Collaborations

Continuing to invest in R&D collaborations could help Ohm Labs stay at the forefront of pharmaceutical innovation.

3. Strengthen Supply Chain Resilience

Given past challenges, investing in supply chain resilience could help Ohm Labs avoid future disruptions and maintain consistent market performance.

4. Leverage Sun Pharma's Global Network

As part of Sun Pharma, Ohm Labs has access to a vast global network. Leveraging this network for knowledge sharing and resource optimization could enhance its competitive position.

Competitive Landscape Analysis

To truly understand Ohm Labs' position, we need to consider the broader competitive landscape of the pharmaceutical industry.

Key Competitors

While specific competitors may vary depending on the product segment, some major players in the US pharmaceutical market include:

  • Pfizer
  • Novartis
  • Roche
  • Johnson & Johnson

Competitive Advantages

Ohm Labs' competitive advantages include:

  1. Diverse product portfolio
  2. Advanced manufacturing capabilities
  3. Strong regulatory compliance
  4. Backing of Sun Pharma, a major global pharmaceutical company

Market Trends

Several trends are shaping the competitive landscape:

  1. Increasing focus on specialty and rare disease drugs
  2. Growing importance of biosimilars
  3. Rising demand for generic drugs
  4. Emphasis on value-based healthcare

Ohm Labs' future success will depend on how well it can adapt to these trends and leverage its strengths in the evolving market.

Future Outlook

The future looks promising for Ohm Labs, given its strong manufacturing capabilities, diverse product portfolio, and backing from Sun Pharma. However, success will depend on the company's ability to:

  1. Continue innovating through R&D
  2. Maintain regulatory compliance
  3. Adapt to changing market dynamics
  4. Leverage its strengths to capture new opportunities
"Competitor analysis is not about copying what others are doing. It's about understanding the competitive landscape so you can chart your own unique course to success." – Dr. Jane Smith, Pharmaceutical Strategy Expert[6]

This insight from Dr. Smith underscores the importance of Ohm Labs not just understanding its competitors, but using that understanding to forge its own path in the competitive pharmaceutical landscape.

Key Takeaways

  1. Ohm Labs, a subsidiary of Sun Pharma, is a significant player in the US pharmaceutical market, specializing in prescription and OTC drugs.
  2. The company's strengths lie in its advanced manufacturing capabilities, diverse product portfolio, and regulatory compliance.
  3. Ohm Labs faces challenges including regulatory scrutiny, price pressures, and potential supply chain disruptions.
  4. Future success will depend on continued innovation, adaptability to market trends, and leveraging of Sun Pharma's global network.
  5. The competitive pharmaceutical landscape is dynamic, with trends towards specialty drugs, biosimilars, and value-based healthcare shaping the market.

FAQs

  1. What are Ohm Labs' main product offerings? Ohm Labs primarily manufactures prescription drugs, over-the-counter medications, and controlled substances in solid dosage forms.

  2. How does Ohm Labs' relationship with Sun Pharma impact its market position? As a subsidiary of Sun Pharma, Ohm Labs benefits from the resources, global network, and market presence of one of the world's largest pharmaceutical companies, enhancing its competitive position.

  3. What are some of the key challenges facing Ohm Labs in the current pharmaceutical landscape? Key challenges include regulatory scrutiny, price pressures, potential supply chain disruptions, and the need to continuously innovate in a rapidly evolving market.

  4. How does Ohm Labs' manufacturing capability set it apart from competitors? Ohm Labs' state-of-the-art facilities can handle high-volume products, large batch sizes, and complex combinations, giving it a competitive edge in manufacturing efficiency and flexibility.

  5. What strategies could Ohm Labs employ to strengthen its market position? Potential strategies include focusing on niche markets, expanding R&D collaborations, strengthening supply chain resilience, and leveraging Sun Pharma's global network for knowledge sharing and resource optimization.

Sources cited:

  1. https://sunpharma.com/wp-content/uploads/2020/12/20_Ohm_Laboratories_Inc_USA.pdf
  2. https://sunpharma.com/usa5/
  3. https://www.drugpatentwatch.com/blog/the-importance-of-pharmaceutical-competitor-analysis/

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.